Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. Among authors: jager u. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patients.
Knefel M, Zeilinger EL, Lubowitzki S, Krammer K, Unseld M, Bartsch R, Fuereder T, Jäger U, Kiesewetter B, Krauth M, Raderer M, Staber PB, Valent P, Gaiger A. Knefel M, et al. Among authors: jager u. Cancer. 2023 Nov 1;129(21):3466-3475. doi: 10.1002/cncr.34953. Epub 2023 Jul 20. Cancer. 2023. PMID: 37470252 Free article.
Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Friedberg E, Wohlfarth P, Schiefer AI, Skrabs C, Pickl WF, Worel N, Staber P, Jäger U, Ay C. Friedberg E, et al. Among authors: jager u. J Thromb Haemost. 2024 Oct 10:S1538-7836(24)00572-5. doi: 10.1016/j.jtha.2024.09.024. Online ahead of print. J Thromb Haemost. 2024. PMID: 39393780 Free article.
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients.
Zeilinger EL, Knefel M, Erfurth A, Andrzejewski D, Lesch O, Sturtzel C, Unseld M, Lubowitzki S, Bartsch R, Fuereder T, Jäger U, Kiesewetter B, Krauth MT, Prager G, Raderer M, Staber PB, Valent P, Gaiger A. Zeilinger EL, et al. Among authors: jager u. J Psychosom Res. 2024 Dec 12;189:112015. doi: 10.1016/j.jpsychores.2024.112015. Online ahead of print. J Psychosom Res. 2024. PMID: 39689404 Free article.
Affective temperament, fatigue, and pain in cancer patients.
Knefel M, Zeilinger EL, Erfurth A, Lubowitzki S, Lesch O, Wagner T, Unseld M, Bartsch R, Füreder T, Jäger U, Kiesewetter B, Krauth MT, Prager G, Raderer M, Staber PB, Valent P, Gaiger A. Knefel M, et al. Among authors: jager u. J Affect Disord. 2023 Nov 1;340:80-87. doi: 10.1016/j.jad.2023.08.003. Epub 2023 Aug 4. J Affect Disord. 2023. PMID: 37543112 Free article. No abstract available.
Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle.
Lickefett B, Chu L, Ortiz-Maldonado V, Warmuth L, Barba P, Doglio M, Henderson D, Hudecek M, Kremer A, Markman J, Nauerth M, Negre H, Sanges C, Staber PB, Tanzi R, Delgado J, Busch DH, Kuball J, Luu M, Jäger U. Lickefett B, et al. Among authors: jager u. Front Immunol. 2023 Dec 22;14:1303935. doi: 10.3389/fimmu.2023.1303935. eCollection 2023. Front Immunol. 2023. PMID: 38187393 Free PMC article. Review.
Somatic Recombination Between an Ancient and a Recent NOTCH2 Gene Variant Is Associated with the NOTCH2 Gain-of-Function Phenotype in Chronic Lymphocytic Leukemia.
Hubmann R, Hilgarth M, Löwenstern T, Lienhard A, Sima F, Reisinger M, Hobel-Kleisch C, Porpaczy E, Haferlach T, Hoermann G, Laccone F, Jungbauer C, Valent P, Staber PB, Shehata M, Jäger U. Hubmann R, et al. Among authors: jager u. Int J Mol Sci. 2024 Nov 22;25(23):12581. doi: 10.3390/ijms252312581. Int J Mol Sci. 2024. PMID: 39684291 Free PMC article.
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Morschhauser F, Dahiya S, Palomba ML, Martin Garcia-Sancho A, Reguera Ortega JL, Kuruvilla J, Jäger U, Cartron G, Izutsu K, Dreyling M, Kahl B, Ghesquieres H, Ardeshna K, Goto H, Barbui AM, Abramson JS, Borchmann P, Fleury I, Mielke S, Skarbnik A, de Vos S, Kamdar M, Karmali R, Viardot A, Farazi T, Fasan O, Lymp J, Vedal M, Nishii R, Avilion A, Papuga J, Kumar J, Nastoupil LJ. Morschhauser F, et al. Among authors: jager u. Nat Med. 2024 Aug;30(8):2374. doi: 10.1038/s41591-024-03175-4. Nat Med. 2024. PMID: 38982297 Free PMC article. No abstract available.
303 results